J&J’s Poon Joins Management Triumvirate With Vice Chairman Appointment
This article was originally published in The Pink Sheet Daily
Executive Summary
Worldwide Chairman-Medicines & Nutritionals Christine Poon joins the Office of the Chairman, which includes CEO Weldon and CFO Darretta. Poon retains management responsibility for the pharmaceutical business.
You may also be interested in...
Johnson & Johnson’s Scodari Announces Retirement As Firm Reorganizes
Christine Poon will assume direct responsibility for the firm’s pharmaceutical and biologics business.
Johnson & Johnson’s Scodari Announces Retirement As Firm Reorganizes
Christine Poon will assume direct responsibility for the firm’s pharmaceutical and biologics business.
Guidant Clarifies J&J Merger Terms, Incentives For Execs, Antitrust Defense
Drug-eluting stent market will prove “sufficiently competitive” for FTC when U.S. pipeline is considered, Guidant CEO Dollens says in justifying the company’s expectation that no material divestitures will result from acquisition by J&J. Guidant exec affirms that preserving “iterative capability” of DES, delivery systems is central to merger plans.